Tumor suppressor functions of ARLTS1 in lung cancers.

ARLTS1 is a newly characterized tumor suppressor gene located at chromosome 13q14.3 and involved in the pathogenesis of various types of tumors: two single-nucleotide polymorphisms, one of them responsible for protein truncation, were found statistically associated with familial malignancies, whereas DNA hypermethylation and genomic deletions have been identified as a mechanism of ARLTS1 down-regulation in sporadic cancers. We found that in a large portion of lung carcinomas (37%) and in all analyzed lung cancer cell lines, ARLTS1 is strongly down-regulated due to DNA methylation in its promoter region. After its restoration by adenoviral transduction, ARLTS1-negative A549 and H1299 cells underwent apoptosis and inhibition of cell growth. Furthermore, ARLTS1 reexpression significantly reduced the ability of A549 and H1299 to form tumors in nude mice. Finally, we identified approximately 650 transcripts differentially expressed after restoration of ARLTS1 expression in A549 cells, suggesting that various pathways involved in cell survival, proliferation, signaling, and development mediate the effects of wild-type ARLTS1 in a lung cancer system.

[1]  B. Burwinkel,et al.  Familial cancer and ARLTS1. , 2005, The New England journal of medicine.

[2]  M. Su,et al.  A novel human protease similar to the interleukin‐1 beta converting enzyme induces apoptosis in transfected cells. , 1995, The EMBO journal.

[3]  A. Aventín,et al.  Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies. , 1998, Blood.

[4]  P-C Chang,et al.  DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control , 2006, Oncogene.

[5]  L. Chin,et al.  High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. , 2006, Cancer cell.

[6]  J. Moss,et al.  Molecules in the ARF Orbit* , 1998, The Journal of Biological Chemistry.

[7]  References , 1971 .

[8]  M. Spitz,et al.  Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q , 1999, Oncogene.

[9]  C. Der,et al.  The ras superfamily of GTP‐binding proteins: guidelines on nomenclature , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  P. Bugert,et al.  Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk , 2006, International journal of cancer.

[11]  A. Godzik,et al.  CARD6 Is a Modulator of NF-κB Activation by Nod1- and Cardiak-mediated Pathways* , 2003, Journal of Biological Chemistry.

[12]  R. Houlston,et al.  Familial cancer associated with a polymorphism in ARLTS1. , 2006, The New England journal of medicine.

[13]  G. Pasinetti,et al.  A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis , 2003, Molecular and Cellular Neuroscience.

[14]  K. Hemminki,et al.  ARLTS1 variants and melanoma risk , 2006, International journal of cancer.

[15]  H. Brenner,et al.  ARLTS1 variants and risk of colorectal cancer. , 2006, Cancer letters.

[16]  C. Putterman,et al.  The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. , 2004, Frontiers in bioscience : a journal and virtual library.

[17]  Yan-Hwa Wu Lee,et al.  DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. , 2006, Cancer research.

[18]  R. Houlston,et al.  Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia. , 2006, Leukemia research.

[19]  R. Kahn,et al.  Arf family GTPases: roles in membrane traffic and microtubule dynamics. , 2005, Biochemical Society transactions.

[20]  D. Iliopoulos,et al.  Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. , 2006, Cancer research.

[21]  M. Spitz,et al.  Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3 , 1999, Oncogene.

[22]  M. Serrano,et al.  Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence. , 2002, Experimental cell research.

[23]  R. Scott,et al.  Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene , 2006, Breast Cancer Research and Treatment.

[24]  Y. Hsu,et al.  Mouse and human neuronal pentraxin 1 (NPTX1): conservation, genomic structure, and chromosomal localization. , 1996, Genomics.

[25]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.